Analysis of Maternal and Congenital Syphilis Rates at a New Jersey University Hospital

Paige Heiman1, Vineet Bhandari1,2, Sarah Davenport3,4

  • 1Cooper Medical School of Rowan University, Camden, NJ 08103, USA.

PubMed

Insights

Congenital syphilis (CS) rates are rising, exacerbated by the COVID-19 pandemic. Improvements in prenatal care and timely maternal syphilis treatment are crucial to reduce transmission and improve outcomes.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Maternal-Fetal Medicine

Background:

  • Syphilis and congenital syphilis (CS) rates have been increasing globally since the 2000s.
  • Social determinants and the COVID-19 pandemic may be contributing factors to rising syphilis transmission.

Purpose of the Study:

  • To quantify the rise in CS rates at a large urban hospital.
  • To assess the impact of the COVID-19 pandemic on CS rates.

Main Methods:

  • Retrospective chart review of 61 pregnant women diagnosed with syphilis.
  • Data collected from January 2016 to June 2022 at an urban academic hospital.

Main Results:

  • Maternal syphilis and CS rates significantly increased over the study period, especially around the COVID-19 pandemic.
  • Inadequate prenatal care, screening, and treatment were observed in a significant proportion of mothers.
  • Homelessness and past opioid use were associated with increased CS risk.
  • Stillbirth occurred in 6.6% of pregnancies; 97.6% of liveborn infants received appropriate treatment, but only 45.1% had adequate follow-up.

Conclusions:

  • Maternal syphilis and CS rates have risen at the study hospital, with a notable increase during the COVID-19 pandemic.
  • Gaps in prenatal care access and timely maternal treatment require targeted interventions.
  • Addressing social factors like homelessness and opioid use is essential for CS prevention.